<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="Content-Style-Type" content="text/css" />
  <meta name="generator" content="pandoc" />
  <title></title>
  <style type="text/css">code{white-space: pre;}</style>
</head>
<body>
<h3 id="mondo0018365"><a href="http://purl.obolibrary.org/obo/MONDO_0018365">MONDO:0018365</a></h3>
<p><strong>Label:</strong> malignant non-epithelial tumor of ovary</p>
<p><strong>Subclasses:</strong> <a href="http://purl.obolibrary.org/obo/MONDO_0016248">MONDO:0016248</a> (familial ovarian cancer), <a href="http://purl.obolibrary.org/obo/MONDO_0015442">MONDO:0015442</a> (hereditary breast and ovarian cancer syndrome), <a href="http://purl.obolibrary.org/obo/MONDO_0011366">MONDO:0011366</a> (ovarian germ cell cancer), <a href="http://purl.obolibrary.org/obo/MONDO_0018172">MONDO:0018172</a> (malignant sex cord stromal tumor of ovary), <a href="http://purl.obolibrary.org/obo/MONDO_0018171">MONDO:0018171</a> (malignant germ cell tumor of ovary),</p>
<p><strong>Corr. equiv. classes:</strong> <a href="http://purl.obolibrary.org/obo/OMIM_613399">OMIM:613399</a>, <a href="http://www.orpha.net/ORDO/Orphanet_213517">Orphanet:213517</a>, <a href="http://www.orpha.net/ORDO/Orphanet_145">Orphanet:145</a>, <a href="http://purl.obolibrary.org/obo/OMIM_612555">OMIM:612555</a>, <a href="http://purl.obolibrary.org/obo/OMIM_603737">OMIM:603737</a>, <a href="http://purl.obolibrary.org/obo/OMIM_614291">OMIM:614291</a>, <a href="http://www.orpha.net/ORDO/Orphanet_35808">Orphanet:35808</a>, <a href="http://purl.obolibrary.org/obo/OMIM_604370">OMIM:604370</a>, <a href="http://www.orpha.net/ORDO/Orphanet_35807">Orphanet:35807</a>,</p>
<p><strong>Class expressions from DL-Learner:</strong></p>
<ul>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0025033">HP:0025033</a> (Abnormality of digestive system morphology))) 49.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0012718">HP:0012718</a> (Morphological abnormality of the gastrointestinal tract))) 49.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002242">HP:0002242</a> (Abnormality of the intestine))) 49.40%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0002250">HP:0002250</a> (Abnormality of the large intestine))) 47.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0001574">HP:0001574</a> (Abnormality of the integument))) 47.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000951">HP:0000951</a> (Abnormality of the skin))) 47.29%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0010786">HP:0010786</a> (Urinary tract neoplasm))) 44.05%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0009725">HP:0009725</a> (Bladder neoplasm))) 39.81%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000771">HP:0000771</a> (Gynecomastia))) 39.81%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000160">HP:0000160</a> (Narrow mouth))) 38.32%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000034">HP:0000034</a> (Hydrocele testis))) 38.32%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) 36.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000016">HP:0000016</a> (Urinary retention))) 36.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000013">HP:0000013</a> (Hypoplasia of the uterus))) 36.53%</li>
<li><a href="http://purl.obolibrary.org/obo/HP_0003002">HP:0003002</a> (Breast carcinoma) and (not (<a href="http://purl.obolibrary.org/obo/HP_0000012">HP:0000012</a> (Urinary urgency))) 36.53%</li>
</ul>
</body>
</html>
